Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial

Jones, J.R., Cairns, D.A. orcid.org/0000-0002-2338-0179, Menzies, T. et al. (14 more authors) (2023) Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial. eClinicalMedicine, 62. 102099. ISSN 2589-5370

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Keywords: Myeloma; Lenalidomide; Lenalidomide maintenance; Second primary malignancy; SPM; Transplant eligible; Transplant non-eligible
Dates:
  • Published: August 2023
  • Published (online): 27 July 2023
  • Accepted: 28 June 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 27 Jun 2024 10:49
Last Modified: 27 Jun 2024 10:49
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.eclinm.2023.102099
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics